RESMED INC — Director's Dealing 2017

Aug 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-08-17

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-17	ResMed Common Stock	A	36265	—	Acquired	47149	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	91368	Indirect

Footnotes

F1: Represents performance-based restricted stock units initially granted on November 16, 2016. The shares were earned on August 17, 2017, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3 each year on the anniversary of the grant.

F2: Includes 210.30 shares of ResMed stock purchased on April 28, 2017, through the ResMed Employee Stock Purchase Plan.